Johnson & Johnson Tops Earnings Estimates
The health care giant's quarterly earnings and sales clocked in well above analyst expectations.
Shares of Johnson & Johnson (JNJ) - Get Report are up Tuesday after the world's biggest maker of health care products topped second quarter forecasts and raised its outlook for the year. The company reported adjusted profits of $1.74 a share, seven cents above forecasts. Sales came in at nearly $18.5 billion, also above estimates. CEO Alex Gorsky said, 'We saw notable strength in our Pharmaceuticals business due to the continued success of new products, and also achieved significant clinical milestones, advancing our robust pipeline.' The company also raised its sales and earnings guidance for the full year.
Employees of TheStreet are restricted from owning individual securities.
